COMP <GO>
GRDN vs WMT // ALTMAN Z-SCORE & DEBT/EQUITY
Guardian Pharmacy Services Inc. (Class A) (NYSE) VS. Walmart Inc. (NYSE) • 15-METRIC TALLY: GRDN 6
— WMT 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: GRDN
LAST: $40.45 (+0.30%) • MKT CAP: $2.56B
balance-sheet
12.39
LAST: $121.25 (+2.09%) • MKT CAP: $961.97B
balance-sheet
6.23
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDN VS. WMT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRDN | WMT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.20% | 25.23% | -5.03 | WMT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.70% | 20.14% | +17.56 | GRDN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.3x | 22.5x | +11.80 | WMT | /valuation <GO> |
| Free Cash Flow Yield | 3.91% | 1.39% | +2.52 | GRDN | /fcf-yield <GO> |
| Operating Margin | 5.00% | 4.39% | +0.61 | GRDN | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 3.00% | +0.40 | GRDN | /net-margins <GO> |
| Revenue Growth (YoY) | 17.90% | 6.16% | +11.74 | GRDN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.80% | -0.80 | WMT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 12.39 | 6.23 | +6.16 | GRDN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.38% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.3 | 57.7 | -8.40 | WMT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.57 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.8x | 39.4x | +4.40 | WMT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.56B | $961.97B | -$959.40B | WMT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRDN REV | WMT REV | GRDN GROSS % | WMT GROSS % | GRDN FCF | WMT FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $713.16B | — | 24.9% | — | $14.92B |
| FY 2025 | $1.45B | $680.99B | 20.2% | 24.9% | $100.3M | $12.66B |
| FY 2024 | $1.23B | $648.13B | 19.9% | 24.4% | $58.0M | $15.12B |
| FY 2023 | — | $611.29B | — | 24.1% | — | $11.98B |
| FY 2022 | — | $572.75B | — | 25.1% | — | $11.07B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDN // BETA —
WMT // BETA 0.57